Starling Oncology, Inc.

STLNW

Exchange: Nasdaq
Industry: Services-Offices & Clinics of Doctors of Medicine
SEC CIK: 0001799191

SEC filings (opens in a new tab)

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.

Other share classesDFPH STLN

Q3 2023 vs. Q2 2023

How the institutions holding Starling Oncology, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of STLNW: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	15	15	0
Shares	4.29M	4.35M	+62.1K (+1.4%)
Value	$132.4K	$406.9K	+$274.4K (+207.3%)

New holders (2)

Institutions that held Starling Oncology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to STLNW in Q3 2023
Institution	Shares	Value	% of portfolio
Josh Arnold Investment Consultant, LLC	390,041	$35.1K	0.04%
UBS Group AG	1,034	$88	0.00%

Sold out (2)

Institutions that held Starling Oncology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of STLNW in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Highbridge Capital Management LLC	–	$7.32K
Difesa Capital Management, LP	82,749	$3.72K